The MacArthur Competence Assessment Tools for assessing decision-making capacity in schizophrenia: A meta-analysis

Abstract

ObjectiveThis meta-analysis aimed to examine the decisional capacity measured by the MacArthur Competence Assessment Tools (MacCAT) in schizophrenia. MethodEnglish (PubMed, PsycINFO, Embase, Cochrane Library databases and the Cochrane Controlled Trials Register) and Chinese (Wan Fang Database and Chinese National Knowledge Infrastructure) databases were systematically and independently searched from 1995 until August 1, 2016. Weighted and standardized mean differences were calculated. The random effects model was used in all cases. ResultsAltogether 10 studies were identified, with 7 studies using the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR) and 3 studies using the MacArthur Competence Assessment Tool for Treatment (MacCAT-T). The meta-analysis showed that there was significant impairment in decision-making capacity in schizophrenia patients compared to the healthy control group in terms of Understanding (SMD=−0.81, 95% CI: −1.06 to −0.56, P<0.001), Reasoning (SMD=−0.57, 95% CI: −0.80 to −0.34, P<0.001), Appreciation (SMD=−0.87, 95% CI: −1.20 to −0.53, P<0.001), and Expression a choice (SMD=−0.24, 95% CI: −0.43 to −0.05, P=0.01). ConclusionCompared to the control group, schizophrenia patients are more likely to have impaired decision-making capacity in clinical research and treatment as measured by the MacCAT instruments. Researchers and clinicians need to consider the impaired decisional capacity in schizophrenia patients providing informed consent.